PM360, a publication for marketing decision makers in the pharmaceutical, biotech, and medical device industries, held its 2018 Trailblazer Awards Gala in New York City. Joshua Lapsker, Chairman of MediSolutions, was awarded the first-ever Vanguard Award.
New this year, the award recognized an industry pioneer who developed a new service, strategy, product, or technology that greatly impacted the industry Joshua Lapsker, who invented the concept of advertising inside the prescription pad 35 years ago, was selected due to his sustained originality and his positive effect on the healthcare marketing business.
The PM360 Trailblazer Awards have accredited outstanding achievement and innovation in healthcare marketing for almost a decade. The award finalists are selected by the PM360 Editorial Advisory Board, which is comprised of some of the most forward-thinking leaders in their respective fields.
“To be honored with such a prestigious distinction from other leaders in the field is an incredible acknowledgement. MediScripts has helped hundreds of brands achieve their promotional goals of raising product and message awareness and delivering a wonderful return on investment, all while positively impacting the patient/physician relationship,” stated Joshua Lapsker.
Nevertheless, his lifetime achievement extends far beyond prescription pads. Since the commencement of their first advertising medium, MediScripts™ in 1981, MediSolutions now works with a vast physician nationwide network and predicts exponential growth through itsground-breaking virtual reality tool, MediVRx, which will use cutting-edge technology to advance the way physicians and patients interact.
And, due to Lapsker’s vision, he has successfully assembled a powerful team of innovators and marketers, including his own son, Erez Lapsker, who recently took on the position as Chief Executive Officer to further the MediSolutions’ mission to bring MediVRx to the forefront of patient education, care and adherence.
Erez Lapsker, who presented the Vanguard Award to his father explained, “I am so proud of all that he has accomplished. I have some big shoes to fill. This is an exciting new chapter for MediSolutions where we are building on my father’s past success and entering into an expanding marketplace for both the patient and the physician.”
Erez Lapsker, will be leading the company into this next phase with the continued focus on improving the patient experience.
“As the incoming CEO, I’m looking forward to driving continued success for MediSolutions. In the coming weeks, we will be going live with our new MediVRx platform as a tool to maximize the impact of medical communication,” explained Erez Lapsker. ” In fact, we soon plan to announce the results of asignificant trial showing the impactful benefits for patient use as well.”
Receiving full support from his father, Joshua noted that “with Erez’s experience and proven track record of leadership in pharma and biotech digital innovation, I have no doubt that my son will lead MediSolutions into the next phase of unrelenting success.”